tiprankstipranks
Evogene (EVGN)
NASDAQ:EVGN
Holding EVGN?
Track your performance easily

Evogene (EVGN) Financial Statements

579 Followers

Evogene Financial Overview

Evogene's market cap is currently ―. The company's EPS TTM is $-4.446; its P/E ratio is -0.38; Evogene is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 466.00K$ 312.00K$ 237.00K
Gross Profit--$ 346.00K$ 50.00K$ 74.00K
EBIT--$ -6.90M$ -7.56M$ -8.01M
EBITDA--$ -6.26M$ -6.95M$ -7.33M
Net Income Common Stockholders--$ -6.54M$ -8.82M$ -8.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 31.06M$ 6.38M$ 37.95M$ 35.25M$ 44.56M
Total Assets$ 51.10M$ 56.13M$ 59.39M$ 56.66M$ 66.88M
Total Debt$ 1.14M$ 1.82M$ 11.93M$ 2.12M$ 2.50M
Net Debt$ -29.93M$ -4.56M$ -26.02M$ -33.13M$ -42.05M
Total Liabilities$ 22.42M$ 21.57M$ 21.09M$ 11.27M$ 12.15M
Stockholders Equity$ 12.05M$ 27.93M$ 30.58M$ 36.95M$ 45.53M
Cash Flow-
Free Cash Flow--$ -7.28M$ -6.96M$ -8.15M
Operating Cash Flow--$ -7.06M$ -6.66M$ -7.71M
Investing Cash Flow--$ -22.00K$ 1.76M$ 11.98M
Financing Cash Flow--$ 10.17M$ -369.00K$ -100.00K
Currency in USD

Evogene Earnings and Revenue History

Evogene Debt to Assets

Evogene Cash Flow

Evogene Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis